查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1701982

2025 年至 2033 年气雾剂输送设备市场报告（按产品、应用（气喘、慢性阻塞性肺病、囊性纤维化、非呼吸系统疾病）、配销通路和地区划分）

Aerosol Delivery Devices Market Report by Product, Application (Asthma, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, Non-Respiratory Diseases), Distribution Channel, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球气雾剂输送装置市场规模达 495 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 752 亿美元，2025-2033 年期间的成长率 (CAGR) 为 4.8%。市场的主要驱动因素是呼吸系统疾病发病率的上升、吸入技术的进步、老年人口的增长、医疗保健成本的上升以及全球对定製药物可用性的认识的提高。

气雾剂输送装置用于输送药物和治疗呼吸系统疾病，例如气喘、阻塞性肺病、囊性纤维化、肺动脉高压、传染性肺病。它们降低了剂量要求，减少了全身不良反应，并提高了患者自我用药的能力。一些常见的气雾剂输送装置是加压定量吸入器、雾化器和带阀容器。目前，随着新型大分子药物的出现，智慧气雾剂给药装置已应用于糖尿病、镇痛、甲状腺疾病、遗传性疾病等非呼吸系统疾病的治疗。

气雾剂输送装置市场趋势：

冠状病毒病（COVID-19）在全球爆发，导致患者急性呼吸道感染，这是推动气雾剂输送装置需求的关键因素之一。这些设备有助于在家中和医疗保健环境中治疗阻塞性呼吸道疾病。除此之外，由于空气污染水平、过敏原和职业风险的增加，慢性呼吸道感染的盛行率不断上升，以及吸烟和饮酒人数的增加，正在推动市场的成长。此外，老年人口的大幅增加，更容易患上严重的健康疾病，对方便、经济的便携式吸入装置的需求产生了积极影响。除此之外，市场参与者正在开发新型气雾输送装置，帮助治疗肺部慢性发炎和感染，并改善囊性纤维化 (CF) 患者的呼吸道清除。此外，他们还透过电子商务管道提供具有自动记忆功能且易于旅行时使用的迷你超音波雾化器和吸入器。这与个人化药物治疗需求的不断增长以及越来越多地使用线上管道购买医疗用品一起推动了市场的发展。

本报告回答的关键问题

  • 2024 年全球气雾剂输送装置市场规模？ 2025 年至 2033 年期间全球气雾剂输送装置市场的预期成长率为何？
  • 推动全球气雾剂输送装置市场发展的关键因素有哪些？
  • COVID-19 对全球气雾剂输送装置市场有何影响？
  • 根据产品，全球气雾剂输送装置市场是如何分布的？
  • 根据配销通路，全球气雾剂输送装置市场如何分布？
  • 全球气雾剂输送装置市场的主要区域有哪些？
  • 全球气雾剂输送装置市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球气雾剂输送装置市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 干粉吸入器
    • 关键部分
      • 单剂量吸入器
      • 多剂量吸入器
  • 定量吸入器
    • 关键部分
      • 传统加压吸入器
      • 软雾吸入器
  • 雾化器
    • 关键部分
      • 喷射雾化器
      • 超音波雾化器
      • 振动网状雾化器

第七章：市场区隔：依应用

  • 气喘
  • 慢性阻塞性肺病（COPD）
  • 囊肿纤维化
  • 非呼吸系统疾病
    • 关键部分
      • 糖尿病
      • 镇痛
      • 帕金森氏症

第八章：市场区隔：按配销通路

  • 零售药局
  • 医院药房
  • 网上商店

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • 3M Company
    • Aerogen
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Koninklijke Philips NV
    • Merck & Co. Inc.
    • Metall Zug AG
    • Recipharm AB (publ)
    • Teva Pharmaceutical Industries Ltd.
    • Vectura Group plc
Product Code: SR112025A4892

The global aerosol delivery devices market size reached USD 49.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 75.2 Billion by 2033, exhibiting a growth rate (CAGR) of 4.8% during 2025-2033. The market is primarily driven by the rising rates of respiratory illnesses, improvements in inhalation technology, growing geriatric population, rising healthcare costs, and a growing global awareness regarding the availability of customized medicine.

Aerosol delivery devices are used in drug delivery and treating respiratory disorders, such as asthma, obstructive lung diseases, cystic fibrosis, pulmonary arterial hypertension, infectious pulmonary. They lower dosage requirements, reduce systemic adverse effects and improve the ability of patients to self-administer medication. Some of the commonly available aerosol delivery devices are pressurized metered-dose inhalers, nebulizers, and valved holder chambers. At present, smart aerosol drug delivery devices are used in non-respiratory conditions, such as diabetes, analgesia, thyroid disorders, and genetic diseases, due to the advent of novel macromolecular medications.

Aerosol Delivery Devices Market Trends:

The global outbreak of the coronavirus disease (COVID-19) that leads to acute respiratory infections among patients represents one of the key factors driving the need for aerosol delivery devices. These devices assist in treating obstructive airway diseases at home and in healthcare settings. Apart from this, the rising prevalence of chronic respiratory infections due to surging air pollution levels, allergens and occupational risks, and the increasing number of individuals who smoke tobacco and drink is propelling the market growth. Moreover, a considerable rise in the geriatric population, which is more vulnerable to developing serious health illnesses, is positively influencing the demand for portable inhalation devices that are convenient and economical. Besides this, market players are developing novel aerosol delivery devices that help treat chronic inflammation and infection in the lungs and improve airway clearance in patients with cystic fibrosis (CF). Furthermore, they are offering mini ultrasonic nebulizers and inhalers through e-commerce channels that have automatic memory and are easy to use while traveling. This, in confluence with the escalating demand for personalized drug therapy and the increasing use of online channels for purchasing medical supplies, is driving the market.

Key Market Segmentation:

Breakup by Product:

  • Dry Powder Inhalers
  • Single Dose Inhalers
  • Multi Dose Inhalers
  • Metered Dose Inhalers
  • Conventional Pressurized Inhalers
  • Soft Mist Inhalers
  • Nebulizers
  • Jet Nebulizers
  • Ultrasonic Wave Nebulizers
  • Vibrating Mesh Nebulizers

Breakup by Application:

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis
  • Non-Respiratory Diseases
  • Diabetes
  • Analgesia
  • Parkinson's Disease

Breakup by Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Stores

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Aerogen, GlaxoSmithKline plc, Johnson & Johnson, Koninklijke Philips N.V., Merck & Co. Inc., Metall Zug AG, Recipharm AB (publ), Teva Pharmaceutical Industries Ltd. and Vectura Group plc.

Key Questions Answered in This Report

  • 1.What was the size of the global aerosol delivery devices market in 2024?
  • 2.What is the expected growth rate of the global aerosol delivery devices market during 2025-2033?
  • 3.What are the key factors driving the global aerosol delivery devices market?
  • 4.What has been the impact of COVID-19 on the global aerosol delivery devices market?
  • 5.What is the breakup of the global aerosol delivery devices market based on the product?
  • 6.What is the breakup of the global aerosol delivery devices market based on the distribution channel?
  • 7.What are the key regions in the global aerosol delivery devices market?
  • 8.Who are the key players/companies in the global aerosol delivery devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Aerosol Delivery Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Dry Powder Inhalers
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Single Dose Inhalers
      • 6.1.2.2 Multi Dose Inhalers
    • 6.1.3 Market Forecast
  • 6.2 Metered Dose Inhalers
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Conventional Pressurized Inhalers
      • 6.2.2.2 Soft Mist Inhalers
    • 6.2.3 Market Forecast
  • 6.3 Nebulizers
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Jet Nebulizers
      • 6.3.2.2 Ultrasonic Wave Nebulizers
      • 6.3.2.3 Vibrating Mesh Nebulizers
    • 6.3.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Asthma
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chronic Obstructive Pulmonary Disease (COPD)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cystic Fibrosis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Non-Respiratory Diseases
    • 7.4.1 Market Trends
    • 7.4.2 Key Segments
      • 7.4.2.1 Diabetes
      • 7.4.2.2 Analgesia
      • 7.4.2.3 Parkinson's Disease
    • 7.4.3 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Retail Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospital Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3M Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Aerogen
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 GlaxoSmithKline plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Johnson & Johnson
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Koninklijke Philips N.V.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Merck & Co. Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Metall Zug AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Recipharm AB (publ)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Teva Pharmaceutical Industries Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Vectura Group plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Aerosol Delivery Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Aerosol Delivery Devices Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Aerosol Delivery Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Aerosol Delivery Devices Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Aerosol Delivery Devices Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Aerosol Delivery Devices Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Aerosol Delivery Devices Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Aerosol Delivery Devices (Dry Powder Inhalers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Aerosol Delivery Devices (Dry Powder Inhalers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Aerosol Delivery Devices (Metered Dose Inhalers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Aerosol Delivery Devices (Metered Dose Inhalers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Aerosol Delivery Devices (Nebulizers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Aerosol Delivery Devices (Nebulizers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Aerosol Delivery Devices (Asthma) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Aerosol Delivery Devices (Asthma) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Aerosol Delivery Devices (Chronic Obstructive Pulmonary Disease (COPD)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Aerosol Delivery Devices (Chronic Obstructive Pulmonary Disease (COPD)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Aerosol Delivery Devices (Cystic Fibrosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Aerosol Delivery Devices (Cystic Fibrosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Aerosol Delivery Devices (Non-Respiratory Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Aerosol Delivery Devices (Non-Respiratory Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Aerosol Delivery Devices (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Aerosol Delivery Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Aerosol Delivery Devices (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Aerosol Delivery Devices (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Aerosol Delivery Devices (Online Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Aerosol Delivery Devices (Online Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia-Pacific: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia-Pacific: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Latin America: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Latin America: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Brazil: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Brazil: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Mexico: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Mexico: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Middle East and Africa: Aerosol Delivery Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Middle East and Africa: Aerosol Delivery Devices Market: Breakup by Country (in %), 2024
  • Figure 76: Middle East and Africa: Aerosol Delivery Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Global: Aerosol Delivery Devices Industry: SWOT Analysis
  • Figure 78: Global: Aerosol Delivery Devices Industry: Value Chain Analysis
  • Figure 79: Global: Aerosol Delivery Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Aerosol Delivery Devices Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Aerosol Delivery Devices Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Aerosol Delivery Devices Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Aerosol Delivery Devices Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Aerosol Delivery Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Aerosol Delivery Devices Market: Competitive Structure
  • Table 7: Global: Aerosol Delivery Devices Market: Key Players